Watch: New Cancer Drugs from Artificial Life

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “Synthorin” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

http://www.sandiegouniontribune.com/business/biotech/sd-me-synthorx-cancer-20180430-story.html

Follow us on social media for the latest updates in B2B!

Image

Latest

tekniplex
Inside TekniPlex Gaggiano: How Specialized Manufacturing and Precision Engineering Define a True Center of Excellence
April 9, 2026

Manufacturing excellence today is less about scale alone and more about precision, control, and adaptability—especially in industries where even microscopic inconsistencies can have outsized consequences. As global supply chains grow more complex and regulatory standards tighten, facilities that invest in specialized processes and contamination control are quietly becoming the backbone of innovation. Segregated…

Read More
materials
Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026
April 9, 2026

At Paris Packaging Week 2026, Tekniplex didn’t just exhibit—it staged an experience that reflected the evolving intersection of materials science and brand storytelling. The company’s modern booth, complete with a living wall and immersive digital displays, signaled a broader shift in how packaging innovators are choosing to engage a sustainability-conscious audience. Beneath the…

Read More
Paris Packaging
Paris Packaging 2026: How Material Science and Global Innovation Are Reshaping the Future of Packaging
April 9, 2026

In an era where sustainability, performance, and consumer expectations are colliding, packaging has quietly become one of the most dynamic frontiers of innovation. What was once viewed as a functional afterthought is now a strategic lever—one that blends advanced science, manufacturing precision, and an increasingly human-centered understanding of market needs. Material science, in this…

Read More
Gasket
Winning Team Spotlight: How ClearCycle+ Is Redefining Gasket Performance for a Sustainable Future
April 9, 2026

As regulatory pressure mounts ahead of the EU’s anticipated 2027 PFAS-related restrictions, manufacturers are being forced to rethink even the smallest components—like gaskets. TekniPlex’s ClearCycle+ positions itself as a forward-looking solution, addressing persistent industry frustrations such as powder residue and stickiness while aligning with evolving compliance demands. The messaging taps into a broader…

Read More